Gastroenterology — MCQs

A 60-year-old male presents with progressive difficulty in swallowing, vomiting, and occasional regurgitation for the past 3 months. Barium studies showed marked dilatation of the upper esophagus with narrowing of the lower segment. Manometry showed absent esophageal peristalsis. The pathogenesis of this condition is most likely related to:

Q706Medium

Cirrhosis of the liver with portal hypertension occurs in all of the following conditions except:

Q707Medium

Lalloo, 60 years of age, a known case of cirrhosis of the liver, presents with increased levels of Alpha-fetoprotein and hepatomegaly 3 cm below the costal margin. Ultrasonography showed lesions involving the right lobe of the liver. What is the most probable diagnosis?

Q708Easy

The D-Xylose test is primarily used in the diagnosis of which condition?

Q709Easy

For a client in hepatic coma, which outcome indicates the most appropriate improvement?

Q710Hard

A 22-year-old woman with bipolar disorder develops neurologic manifestations over one year, including resting and intention tremors, rigidity, chorea, dysphagia, and dysarthria. Physical examination reveals bilateral Babinski signs. She has ring-like deposits of green material in the corneas bilaterally, without decreased vision. One year later, she experiences a 3-week illness with nausea, vomiting, malaise, and scleral icterus. Laboratory findings include serum AST 100 U/L, ALT 122 U/L, alkaline phosphatase 105 U/L, total bilirubin 4.5 mg/dL, glucose 77 mg/dL, and creatinine 0.9 mg/dL. Serologic tests for hepatitis A, B, and C are negative. This episode resolves without treatment, but she eventually develops cirrhosis. A mutation in a gene encoding for what substance is most likely present in this woman?

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 701: The Bernstein test involves the infusion of 0.1 N HCl into the esophagus. This test is used to diagnose which of the following conditions?

A. Achalasia cardia
B. Diffuse esophageal spasm
C. Gastroesophageal reflux disorder (Correct Answer)
D. Esophageal malignancy

Explanation: **Explanation:** The **Bernstein test** (Acid Perfusion Test) is a provocative test used to determine if a patient’s chest pain or symptoms are related to **Gastroesophageal Reflux Disease (GERD)**. **1. Why the Correct Answer is Right:** The test involves the alternating infusion of normal saline and **0.1 N Hydrochloric Acid (HCl)** into the lower esophagus via a nasogastric tube. In patients with GERD, the esophageal mucosa is often inflamed or sensitized (esophagitis). The infusion of acid mimics physiological reflux; if the patient’s typical symptoms (heartburn or retrosternal pain) are reproduced during the acid infusion but relieved by saline, the test is considered **positive**, confirming that the esophagus is the source of the pain. **2. Why Incorrect Options are Wrong:** * **Achalasia Cardia:** This is a motility disorder characterized by the failure of the Lower Esophageal Sphincter (LES) to relax [1]. Diagnosis is primarily made via **Manometry** (showing "bird-beak" appearance on barium swallow). * **Diffuse Esophageal Spasm (DES):** This is a motility disorder presenting with "corkscrew esophagus." While it causes chest pain, the pain is triggered by swallowing (odynophagia) or spontaneous spasms, not specifically by acid sensitivity [1]. * **Esophageal Malignancy:** Diagnosis requires **Endoscopy and Biopsy** [1]. While malignancy can cause pain, the Bernstein test is not specific or sensitive for structural lesions or neoplastic changes. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for GERD:** The 24-hour ambulatory pH monitoring is the current gold standard, making the Bernstein test largely historical/obsolete in clinical practice, though it remains a favorite for exams. * **Sensitivity vs. Specificity:** The Bernstein test has high specificity but low sensitivity; it only identifies patients whose symptoms are specifically triggered by acid. * **Key Differentiation:** If a patient has chest pain but a negative cardiac workup, the Bernstein test helps differentiate esophageal origin from non-cardiac chest pain.

Question 702: A young boy presented with severe hematemesis. On examination, there was no hepatomegaly, but mild splenomegaly was present. Endoscopy shows esophageal varices. What is the most probable diagnosis?

A. Veno occlusive disease
B. Budd-Chiari syndrome
C. Cirrhosis of the liver
D. Non-cirrhotic portal fibrosis (Correct Answer)

Explanation: ### Explanation The clinical presentation of **severe hematemesis** (due to esophageal varices) and **splenomegaly** in the **absence of hepatomegaly** or signs of liver failure in a young patient is the classic triad of **Non-Cirrhotic Portal Fibrosis (NCPF)**. **1. Why NCPF is the Correct Answer:** NCPF (also known as Idiopathic Portal Hypertension) is characterized by obliterative venopathy of the terminal portal vein branches. This leads to **presinusoidal portal hypertension**. Because the pathology is pre-sinusoidal, the liver parenchyma remains healthy; thus, there is **no hepatomegaly** and liver function tests (LFTs) are typically normal. Patients usually present with features of portal hypertension (splenomegaly and variceal bleeding) rather than liver failure [1] [2]. **2. Why Other Options are Incorrect:** * **Cirrhosis of the Liver:** This is the most common cause of varices, but it typically presents with a shrunken or enlarged firm liver, stigmata of chronic liver disease (ascites, jaundice, spider naevi), and deranged LFTs [1]. * **Budd-Chiari Syndrome:** This involves hepatic venous outflow obstruction. It characteristically presents with a **triad of abdominal pain, ascites, and hepatomegaly** (specifically enlargement of the caudate lobe). * **Veno-occlusive Disease (Sinusoidal Obstruction Syndrome):** This involves the small hepatic venules. It presents with tender hepatomegaly, weight gain (ascites), and jaundice, usually following chemotherapy or bone marrow transplant [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **NCPF vs. EHPVO:** Both cause pre-sinusoidal portal hypertension. However, **Extrahepatic Portal Venous Obstruction (EHPVO)** is characterized by a portal cavernoma on ultrasound, whereas the portal vein is patent in NCPF. * **Schistosomiasis:** The most common cause of non-cirrhotic portal fibrosis worldwide. * **Key Distinction:** In NCPF, the **Hepatic Venous Pressure Gradient (HVPG)** is normal or only slightly elevated, despite significant portal hypertension, because the obstruction is pre-sinusoidal [1].

Question 703: All of the following are criteria for irritable bowel syndrome except?

A. Change in frequency of stool
B. Blood and mucus in stool (Correct Answer)
C. Change in form of stool
D. Improves with defecation

Explanation: **Explanation:** Irritable Bowel Syndrome (IBS) is a **functional gastrointestinal disorder**, meaning it is characterized by symptoms without any underlying structural, inflammatory, or biochemical abnormalities. The diagnosis is primarily clinical, based on the **Rome IV Criteria**. **1. Why "Blood and mucus in stool" is the correct answer:** The presence of blood in the stool is a major **"Red Flag" (Alarm Symptom)** [1]. It suggests an organic pathology such as Inflammatory Bowel Disease (IBD), malignancy, or infection, rather than a functional disorder like IBS. While clear mucus can sometimes be seen in IBS, blood is never a feature [1]. Its presence necessitates further investigation (e.g., colonoscopy). **2. Analysis of other options (Rome IV Criteria):** According to Rome IV, IBS is defined as recurrent abdominal pain (at least 1 day/week in the last 3 months) associated with **two or more** of the following: * **Option D (Related to defecation):** The pain is typically relieved by or associated with defecation [1]. * **Option A (Change in frequency):** Associated with a change in how often the patient has a bowel movement [1]. * **Option C (Change in form):** Associated with a change in the appearance (Bristol Stool Scale) of the stool [1]. **Clinical Pearls for NEET-PG:** * **Manning Criteria:** An older diagnostic tool; "passage of mucus" and "feeling of incomplete evacuation" are included here, but **blood** remains an exclusion [1]. * **Alarm Symptoms (Exclusion Criteria):** Weight loss >5kg, nocturnal diarrhea, anemia, onset after age 50, and family history of colorectal cancer [1]. * **Treatment:** High-fiber diet, antispasmodics (Dicyclomine), and for refractory cases, TCAs or SSRIs.

Question 704: What is the most common cause of non-alcoholic fatty liver disease?

A. Reye syndrome
B. Metabolic syndrome (Correct Answer)
C. Cardiac syndrome-X
D. Pregnancy

Explanation: **Explanation:** **Non-alcoholic Fatty Liver Disease (NAFLD)**, recently renamed **MASLD** (Metabolic Dysfunction-Associated Steatotic Liver Disease), is the most common cause of chronic liver disease worldwide [1]. **1. Why Metabolic Syndrome is Correct:** The pathogenesis of NAFLD is primarily driven by **insulin resistance**, which is the hallmark of **Metabolic Syndrome** [2]. Insulin resistance leads to increased lipolysis in adipose tissue and increased de novo lipogenesis in the liver [3]. This results in the accumulation of triglycerides within hepatocytes (steatosis). Metabolic syndrome—defined by obesity, type 2 diabetes, hypertension, and dyslipidemia—is present in the vast majority of patients with NAFLD. **2. Why Other Options are Incorrect:** * **Reye Syndrome:** This is an acute, life-threatening condition characterized by microvesicular steatosis and encephalopathy, typically occurring in children following a viral illness treated with **aspirin**. It is not a chronic cause of fatty liver. * **Cardiac Syndrome-X:** This refers to microvascular angina (chest pain with normal coronary arteries on angiogram). While it shares risk factors with metabolic syndrome, it is a cardiac diagnosis, not a cause of liver disease. * **Pregnancy:** While **Acute Fatty Liver of Pregnancy (AFLP)** is a serious condition occurring in the third trimester, it is a rare, acute obstetric emergency, not the primary cause of the global NAFLD epidemic. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver biopsy (shows macrovesicular steatosis). * **Most Common Cause of Death:** Cardiovascular disease (not liver failure) [1]. * **First-line Management:** Weight loss (7-10%) and lifestyle modification. * **Key Association:** NAFLD is considered the hepatic manifestation of metabolic syndrome [2].

Question 705: A 60-year-old male presents with progressive difficulty in swallowing, vomiting, and occasional regurgitation for the past 3 months. Barium studies showed marked dilatation of the upper esophagus with narrowing of the lower segment. Manometry showed absent esophageal peristalsis. The pathogenesis of this condition is most likely related to:

A. Reflux of gastric acid into the lower esophagus
B. Abnormal dilatation of the lower esophageal vein
C. Incompetence of the lower esophageal sphincter
D. Absence of ganglion cells in the myenteric plexus of the esophagus (Correct Answer)

Explanation: **Explanation:** The clinical presentation of progressive dysphagia, regurgitation, and characteristic imaging findings (dilated esophagus with distal narrowing) points towards a diagnosis of **Achalasia Cardia**. [1] **Why Option D is Correct:** The primary pathophysiology of Achalasia is the **loss of inhibitory ganglion cells** (nitric oxide and VIP-producing neurons) in the **Auerbach’s (myenteric) plexus** of the esophageal wall. [1] This loss leads to two main functional defects: 1. **Failure of the Lower Esophageal Sphincter (LES) to relax** during swallowing. 2. **Aperistalsis** (absence of organized peristaltic waves) in the distal two-thirds of the esophagus. [1] The resulting functional obstruction causes the proximal esophagus to dilate (mega-esophagus). **Why Other Options are Incorrect:** * **Option A:** Reflux of gastric acid is the hallmark of GERD. In Achalasia, the LES pressure is actually high, preventing reflux. * **Option B:** Dilatation of lower esophageal veins refers to esophageal varices, typically seen in portal hypertension, presenting with hematemesis rather than progressive dysphagia. * **Option C:** Incompetence of the LES leads to GERD. In Achalasia, there is **hypertonicity** or failure of relaxation, not incompetence. **NEET-PG High-Yield Pearls:** * **Gold Standard Investigation:** Esophageal Manometry (shows incomplete LES relaxation and aperistalsis). * **Barium Swallow Finding:** "Bird’s beak" or "Rat-tail" appearance. * **Chagas Disease:** Caused by *Trypanosoma cruzi*, it is a common secondary cause of Achalasia due to destruction of the myenteric plexus. * **Heller’s Myotomy:** The definitive surgical treatment, often combined with a partial fundoplication.

Question 706: Cirrhosis of the liver with portal hypertension occurs in all of the following conditions except:

A. Cystic fibrosis
B. Alpha 1 anti-trypsin deficiency
C. Wilson's disease
D. Schistosomiasis (Correct Answer)

Explanation: The key to this question lies in the distinction between **cirrhosis** and **non-cirrhotic portal hypertension**. While all four options can lead to portal hypertension, **Schistosomiasis** (specifically *S. mansoni* and *S. japonicum*) causes portal hypertension without causing true cirrhosis [1]. **1. Why Schistosomiasis is the correct answer:** In Schistosomiasis, the parasite eggs lodge in the small branches of the portal vein, leading to a granulomatous reaction and intense **"pipestem" fibrosis (Symmers' fibrosis)**. Crucially, this process is **presinusoidal**. Because the pathology is limited to the portal tracts, the liver parenchyma and lobular architecture remain preserved. Since cirrhosis is defined by diffuse fibrosis *and* regenerative nodules that distort the entire liver architecture, Schistosomiasis does not meet the criteria for cirrhosis. **2. Why the other options are incorrect:** * **Wilson’s Disease:** A disorder of copper metabolism that leads to chronic hepatitis, which eventually progresses to macronodular cirrhosis [2]. * **Alpha-1 Antitrypsin Deficiency:** The accumulation of misfolded protein (PiZZ phenotype) in hepatocytes causes chronic liver injury, leading to cirrhosis and an increased risk of hepatocellular carcinoma [2], [3]. * **Cystic Fibrosis:** Thickened biliary secretions cause focal biliary cirrhosis, which can eventually become diffuse and lead to portal hypertension [2]. **Clinical Pearls for NEET-PG:** * **Schistosomiasis** is the most common cause of non-cirrhotic portal hypertension worldwide [1]. * **Presinusoidal Portal Hypertension:** Characterized by normal Wedged Hepatic Venous Pressure (WHVP) but elevated portal venous pressure. * **High-Yield Distinction:** In Schistosomiasis, liver function tests (synthetic function) are often preserved until very late stages, unlike in true cirrhosis where albumin and INR are early markers of failure [1].

Question 707: Lalloo, 60 years of age, a known case of cirrhosis of the liver, presents with increased levels of Alpha-fetoprotein and hepatomegaly 3 cm below the costal margin. Ultrasonography showed lesions involving the right lobe of the liver. What is the most probable diagnosis?

A. Focal nodular hyperplasia
B. Hepatocellular carcinoma (Correct Answer)
C. Hepatic adenoma
D. Metastasis

Explanation: The clinical presentation of a patient with **pre-existing cirrhosis**, new-onset **hepatomegaly**, and significantly **elevated Alpha-fetoprotein (AFP)** levels is a classic triad for **Hepatocellular Carcinoma (HCC)**. In a cirrhotic liver, any new focal lesion should be considered HCC until proven otherwise [1]. AFP is a highly specific tumor marker for HCC when levels are significantly raised (typically >200 ng/mL) [1]. **Why other options are incorrect:** * **Focal Nodular Hyperplasia (FNH):** This is a benign "leave-me-alone" lesion usually found in young females. It is not associated with cirrhosis or elevated AFP and typically shows a characteristic "central stellate scar" on imaging. * **Hepatic Adenoma:** This is a benign tumor strongly associated with oral contraceptive use or glycogen storage diseases. It carries a risk of rupture but does not typically occur in a background of cirrhosis or cause high AFP levels. * **Metastasis:** While the liver is a common site for metastases, they usually present as multiple "umbilicated" nodules. Furthermore, primary liver cirrhosis is a stronger risk factor for primary HCC than for secondary metastasis, and AFP is specific to primary liver cell origin. **High-Yield NEET-PG Pearls:** * **Screening for HCC:** Patients with cirrhosis should undergo screening every 6 months using **Ultrasonography + AFP** [1]. * **Diagnosis:** Unlike most cancers, HCC can often be diagnosed based on imaging (Triphasic CT/MRI) without a biopsy if the lesion shows **arterial phase enhancement** and **venous phase washout** [1]. * **Risk Factors:** Hepatitis B (can cause HCC even without cirrhosis), Hepatitis C, Alcohol, and Aflatoxin B1.

Question 708: The D-Xylose test is primarily used in the diagnosis of which condition?

A. Zinc deficiency
B. Malabsorption syndrome (Correct Answer)
C. Vitamin B12 deficiency
D. Bacterial overgrowth syndrome

Explanation: The **D-Xylose test** is a classic diagnostic tool used to assess the integrity of the proximal small intestinal mucosa. D-Xylose is a pentose sugar that is absorbed via passive diffusion in the jejunum and does not require pancreatic enzymes for digestion. **Why Malabsorption Syndrome is correct:** In conditions causing **mucosal malabsorption** (e.g., Celiac disease, Tropical sprue, or Whipple’s disease), the damaged intestinal lining cannot absorb D-Xylose efficiently [1]. Consequently, blood levels of D-Xylose remain low, and urinary excretion is decreased. This helps clinicians differentiate between **mucosal causes** of malabsorption (low D-Xylose) and **maldigestion** due to pancreatic insufficiency (normal D-Xylose, as pancreatic enzymes are not needed for its absorption) [2]. **Why other options are incorrect:** * **Zinc deficiency:** Diagnosed via serum zinc levels; D-Xylose does not track trace element absorption. * **Vitamin B12 deficiency:** Traditionally assessed via the Schilling test (now largely historical) or serum B12/Methylmalonic acid levels. B12 absorption occurs in the terminal ileum and requires Intrinsic Factor. * **Bacterial overgrowth syndrome (SIBO):** While SIBO can cause a false positive (low D-Xylose) because bacteria metabolize the sugar before absorption, the test is not the primary diagnostic modality [3]. The gold standard for SIBO is a jejunal aspirate culture or carbohydrate breath tests (e.g., Lactulose/Glucose). **High-Yield Clinical Pearls for NEET-PG:** * **Normal Result:** >4g excreted in urine over 5 hours (after a 25g oral dose). * **False Positives:** Low urinary D-Xylose can occur in **renal insufficiency**, ascites, or delayed gastric emptying, even if the mucosa is healthy. * **Key Distinction:** D-Xylose test is **Normal in Chronic Pancreatitis** but **Abnormal in Celiac Disease.**

Question 709: For a client in hepatic coma, which outcome indicates the most appropriate improvement?

A. The client is oriented to time, place, and person. (Correct Answer)
B. The client exhibits no ecchymotic areas.
C. The client increases oral intake to 2,000 calories/day.
D. The client exhibits an increased serum albumin level.

Explanation: ### Explanation **1. Why Option A is Correct:** Hepatic coma is the most severe stage (Stage IV) of **Hepatic Encephalopathy (HE)**. HE is a reversible neuropsychiatric syndrome caused by liver failure and portosystemic shunting, leading to the accumulation of neurotoxins—primarily **ammonia**—in the brain [1]. Since the hallmark of HE is altered mental status and cognitive impairment, the primary clinical indicator of improvement is the restoration of neurological function [1]. A client becoming oriented to time, place, and person signifies a transition from a comatose state back toward a normal mental state (Stage 0). **2. Analysis of Incorrect Options:** * **Option B:** Ecchymosis (bruising) relates to coagulopathy and vitamin K deficiency common in liver disease [2]. While important, it does not reflect the resolution of the acute life-threatening neurological crisis of hepatic coma. * **Option C:** While nutrition is vital in chronic liver disease, an increased caloric intake is a long-term goal. In the acute phase of hepatic coma, the patient is often NPO or on a protein-restricted diet to reduce ammonia production. * **Option D:** Serum albumin reflects the liver's synthetic function over weeks (half-life of ~20 days) [2]. It is a marker of chronic stability, not an indicator of acute recovery from encephalopathy. **3. NEET-PG High-Yield Pearls:** * **Pathogenesis:** Ammonia crosses the blood-brain barrier and is converted to **glutamine** by astrocytes, causing osmotic swelling and cerebral edema. * **Precipitating Factors:** GI bleed (increases nitrogen load), infections (SBP), constipation, and hypokalemia. * **Clinical Sign:** **Asterixis** (flapping tremors) is the classic sign of Stage II/III HE but is absent in Stage IV (coma) as the patient cannot cooperate. * **Management:** **Lactulose** (first-line) converts ammonia ($NH_3$) to non-absorbable ammonium ($NH_4^+$) and acts as an osmotic laxative. **Rifaximin** is added for prevention of recurrence.

Question 710: A 22-year-old woman with bipolar disorder develops neurologic manifestations over one year, including resting and intention tremors, rigidity, chorea, dysphagia, and dysarthria. Physical examination reveals bilateral Babinski signs. She has ring-like deposits of green material in the corneas bilaterally, without decreased vision. One year later, she experiences a 3-week illness with nausea, vomiting, malaise, and scleral icterus. Laboratory findings include serum AST 100 U/L, ALT 122 U/L, alkaline phosphatase 105 U/L, total bilirubin 4.5 mg/dL, glucose 77 mg/dL, and creatinine 0.9 mg/dL. Serologic tests for hepatitis A, B, and C are negative. This episode resolves without treatment, but she eventually develops cirrhosis. A mutation in a gene encoding for what substance is most likely present in this woman?

A. a1-Antitrypsin
B. CFTR
C. Copper-transporting ATPase (Correct Answer)
D. Galactose-1-phosphate uridyltransferase

Explanation: ### Explanation The clinical presentation of a young patient with **neuropsychiatric symptoms** (bipolar disorder, tremors, chorea, dysarthria), **Kayser-Fleischer (KF) rings** (green corneal deposits), and **recurrent liver injury** leading to cirrhosis is pathognomonic for **Wilson Disease** (Hepatolenticular Degeneration) [1]. **1. Why the Correct Answer is Right:** Wilson disease is an autosomal recessive disorder caused by a mutation in the **ATP7B gene** on chromosome 13. This gene encodes a **copper-transporting P-type ATPase** located in the hepatocytes. This protein is essential for: * Incorporating copper into **apoceruloplasmin** to form ceruloplasmin. * Excreting excess copper into the **bile** [2]. Deficiency leads to copper accumulation in the liver, brain (basal ganglia), and cornea, causing the multisystem manifestations described [1]. **2. Why the Other Options are Wrong:** * **A. α1-Antitrypsin:** Deficiency causes neonatal jaundice or adult-onset cirrhosis and emphysema. It does not cause KF rings or extrapyramidal neurological symptoms. * **B. CFTR:** Mutations cause Cystic Fibrosis. While it can cause biliary cirrhosis, the primary features are respiratory infections and pancreatic insufficiency. * **D. Galactose-1-phosphate uridyltransferase:** Deficiency causes classic Galactosemia, which presents in **neonates** with cataracts, hepatomegaly, and jaundice upon starting milk. **3. NEET-PG High-Yield Pearls:** * **Diagnosis:** Best initial test is **Serum Ceruloplasmin** (decreased); Gold standard is **Liver Biopsy** (increased copper content). * **KF Rings:** Located in the **Descemet’s membrane** of the cornea; seen via slit-lamp exam. * **Treatment:** Chelators like **D-Penicillamine** (first-line) or Trientine; Zinc (prevents absorption). * **Hemolysis:** Wilson disease can present with Coombs-negative hemolytic anemia [1].

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free